Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0YX4S
|
||||
Former ID |
DAP000447
|
||||
Drug Name |
Cefprozil
|
||||
Synonyms |
Arzimol; Brisoral; Cefprozilo; Cefprozilum; Cefzil; Cronocef; Procef; Serozil; Cefprozil anhydrous; BMY 28100; Cefprozil (INN); Cefprozil (TN); Cefprozilo [INN-Spanish]; Cefprozilum [INN-Latin]; Cefzil (TN); Procef (TN); (6R,7R)-7-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(E)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-(prop-1-en-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] | Approved | [536361] | ||
Therapeutic Class |
Antibiotics
|
||||
Company |
Bristol-Myers Squibb
|
||||
Structure |
Download2D MOL |
||||
Formula |
C18H19N3O5S
|
||||
Canonical SMILES |
CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
|
||||
InChI |
1S/C18H19N3O5S/c1-2-3-10-8-27-17-13(16(24)21(17)14(10)18(25)26)20-15(23)12(19)9-4-6-11(22)7-5-9/h2-7,12-13,17,22H,8,19H2,1H3,(H,20,23)(H,25,26)/b3-2+/t12-,13-,17-/m1/s1
|
||||
InChIKey |
WDLWHQDACQUCJR-ZAMMOSSLSA-N
|
||||
CAS Number |
CAS 92665-29-7
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9105, 7978884, 8616472, 14829868, 14878480, 39289947, 46504903, 50050887, 50581507, 51091955, 57357964, 92740989, 93166991, 93374680, 103183732, 113854371, 124766216, 126669942, 134224053, 134337743, 135013400, 135019184, 137003420, 137156332, 152035408, 160964484, 164831794, 175270654, 175612228, 176485043, 179116608, 184546470, 198952984, 223685418, 226422930
|
||||
SuperDrug ATC ID |
J01DC10
|
||||
SuperDrug CAS ID |
cas=092665297
|
||||
Target and Pathway | |||||
Target(s) | DNA | Target Info | Binder | [536099] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.